Investor Relations

IR Home

Stock Chart
VNDA (Common)
ExchangeNASDAQ (US Dollar)
Price$15.90
Change (%) Stock is Down 0.2 (1.24%)
Volume1,296,644
Data as of 06/23/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
June 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-4-3-2-1123
45678910
1112131415
06/15/17
S-8
Formats:  Excel HTML Adobe PDF Word
8-K
Formats:  Excel HTML Adobe PDF Word
1617
1819
06/19/17
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
4
Formats:  HTML Adobe PDF Word
SC 13G
Formats:  Excel HTML Adobe PDF Word
2021222324
25262728293051

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

Recent News
06/05/17
Vanda Pharmaceuticals Announces Participation at June 2017 Investor Conferences
05/02/17
Vanda Pharmaceuticals Reports First Quarter 2017 Financial Results
05/01/17
Vanda Pharmaceuticals to Present at the Deutsche Bank 42nd Annual Health Care Conference
More >>
Upcoming Events
There are currently no events scheduled.
More >>
Latest Presentation
Download Documentation JMP Securities 2017 Life Sciences Conference Presentation

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
  
Home | About Vanda | Product Pipeline| Partnering | Investor Relations | News | Careers | Contact Us
Copyright © 2005-2017 Vanda Pharmaceuticals | Terms & Conditions | Privacy Policy